Market Overview

UPDATE: Morgan Stanley Reiterates on athenahealth on Mixed Factors

Related ATHN
Women's Health USA Selects athenahealth To Connect Care
Urban Outfitters Drops On Q4 Profit Warning; Mead Johnson Nutrition Shares Spike Higher

In a report published Monday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Equal-Weight rating on athenahealth (NASDAQ: ATHN), but removed the $133.00 price target.

In the report, Morgan Stanley noted, “First clients for Coordinator Enterprise offering announced, Steward Healthcare, a mid-sized health system (11 hospitals, ~2,100 beds, net oper. revs. of $1.9B and Griffin Hospital (160 bed hospital, with net oper. revs of $130M). Initially, early adopter revenue model is subject to at-risk outcomes, tied to ROI and measured savings metrics. If proof-of-concept materializes, at ATHN's stated goal pricing of 1% of revenues, we estimate these contracts would amount to ~$20M in annual revenues. According to management, measurable outcome data will be available within first 12 month of contract.”

athenahealth closed on Thursday at $145.58.

Latest Ratings for ATHN

DateFirmActionFromTo
Dec 2014CitigroupMaintainsBuy
Dec 2014JP MorganMaintainsOverweight
Oct 2014BarclaysMaintainsEqual-weight

View More Analyst Ratings for ATHN
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Ricky R. GoldwasserAnalyst Color Price Target Analyst Ratings

 

Related Articles (ATHN)

Around the Web, We're Loving...

Get Benzinga's Newsletters